Effect of Male Involvement in Family Planning Education on Contraceptive Use (NCT06450756) | Clinical Trial Compass
CompletedNot Applicable
Effect of Male Involvement in Family Planning Education on Contraceptive Use
Ethiopia1,496 participantsStarted 2022-01-01
Plain-language summary
This study aimed to examine the effect of Male Involvement in Family Planning Education on Contraceptive Use Among Married Couples in the Pastoralist Community of Fentale District, Eastern Ethiopia.
Who can participate
Age range
15 Years – 49 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Married women aged between 15 and 49 years, along with their husbands.
* Non-pregnant women at the time of the study period were included, along with their husbands.
* Only legally married couples were considered.
* Couples who have resided in the village or an area with consistent mobility for the past year.
* Couples cohabiting in the same house within the study area or in areas with mobility were included.
* Couples intending to stay in the district or areas with mobility for at least one year and six months from the data collection period.
* Inclusion of couples where the husband expressed willingness for his wife to participate in the study.
* Only mentally capable couples, ensuring individuals without cognitive impairments, were part of the research.
* Husbands within monogamous marriages (having only one wife) were eligible for analysis.
* Written informed consent was obtained from husbands on behalf of wives under 18, respecting the cultural context and norms of the study area.
Exclusion Criteria:
* Married women not within the reproductive age range (15-49 years old) were excluded from the study, along with their husbands.
* Not Legally married Couples excluded.
* Couples where the husband was unwilling to include his wife in the study were excluded. - Mentally incapable couples, indicating those with cognitive impairments, were not considered in the study.
* Husbands within polygamous marriages (having more than one wife) were also excluded …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.